BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Skin cancer AND ATRX, P46100, ZNF-HX, XNP, XH2, SHS, SFM1, RAD54, MRXHF1, MGC2094, ATR2, 546 AND Treatment
25 results:

  • 1. Diagnostic value of applying preoperative breast ultrasound and clinicopathologic features to predict axillary lymph node burden in early invasive breast cancer: a study of 1247 patients.
    Shao H; Sun Y; Na Z; Jing H; Li B; Wang Q; Zhang C; Cheng W
    BMC Cancer; 2024 Jan; 24(1):112. PubMed ID: 38254060
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Primary mucosal melanomas of the urogenital tract: a clinical, pathological, and genetic nationwide survey of Danish patients 1990-2019.
    Znaider VK; Mikkelsen LH; Jensen CFS; Sønksen J; Heegaard S
    Scand J Urol; 2023 Aug; 58():52-59. PubMed ID: 37635444
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Clinical features of cutaneous infantile hemangioma combined with asymptomatic infantile hepatic hemangioma and efficacy of propranolol treatment.
    Li L; Yu L; Xu Z; Wei L; Zhang B; Han X; Sun Y; Ma L
    J Cosmet Dermatol; 2023 Dec; 22(12):3369-3374. PubMed ID: 37313653
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. sIL-2R- an Immuno-biomarker for Prediction of Metastases in Uveal Melanoma.
    Barak V; Kalickman I; Pe'er J
    Anticancer Res; 2022 Mar; 42(3):1447-1453. PubMed ID: 35220238
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. "Systematic review and meta-analysis of immediate versus delayed autologous breast reconstruction in the setting of post-mastectomy adjuvant radiation therapy".
    Hershenhouse KS; Bick K; Shauly O; Kondra K; Ye J; Gould DJ; Patel KM
    J Plast Reconstr Aesthet Surg; 2021 May; 74(5):931-944. PubMed ID: 33423976
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Serum CD73 is a prognostic factor in patients with metastatic melanoma and is associated with response to anti-PD-1 therapy.
    Turiello R; Capone M; Giannarelli D; Morretta E; Monti MC; Madonna G; Mallardo D; Festino L; Azzaro R; Levesque MP; Imhof L; Weide B; Amaral T; Chevrier M; Sucker A; Rutkowski P; Schadendorf D; Lebbe C; Luke JJ; Wistuba-Hamprecht K; Dummer R; Pinto A; Morello S; Ascierto PA
    J Immunother Cancer; 2020 Dec; 8(2):. PubMed ID: 33361405
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Toxicities of axitinib, sunitinib and temsirolimus: implications for progression-free and overall survival in metastatic renal cell cancer.
    Uhlig A; Uhlig J; Trojan L; Woike M; Leitsmann M; Strauß A
    Future Oncol; 2021 Jan; 17(1):45-56. PubMed ID: 33275038
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Association of bullous pemphigoid and comorbid health conditions: a case-control study.
    Lee S; Rastogi S; Hsu DY; Nardone B; Silverberg JI
    Arch Dermatol Res; 2021 Jul; 313(5):327-332. PubMed ID: 32647978
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Integrative Exome and Transcriptome Analysis of Conjunctival Melanoma and Its Potential Application for Personalized Therapy.
    Demirci H; Demirci FY; Ciftci S; Elner VM; Wu YM; Ning Y; Chinnaiyan A; Robinson DR
    JAMA Ophthalmol; 2019 Dec; 137(12):1444-1448. PubMed ID: 31647501
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Intravitreal aflibercept for the treatment of radiation-induced macular edema after ruthenium 106 plaque radiotherapy for choroidal melanoma.
    Fallico M; Reibaldi M; Avitabile T; Longo A; Bonfiglio V; Chronopoulos A; Caltabiano R; Spatola C; Russo A
    Graefes Arch Clin Exp Ophthalmol; 2019 Jul; 257(7):1547-1554. PubMed ID: 31081526
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Prolonged overall survival following metastasectomy in stage IV melanoma.
    Elias ML; Behbahani S; Maddukuri S; John AM; Schwartz RA; Lambert WC
    J Eur Acad Dermatol Venereol; 2019 Sep; 33(9):1719-1725. PubMed ID: 31070816
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Female genitourinary tract melanoma: mutation analysis with clinicopathologic correlation: a single-institution experience.
    Saglam O; Naqvi SMH; Zhang Y; Mesa T; Teer JK; Yoder S; Lee J; Messina J
    Melanoma Res; 2018 Dec; 28(6):586-591. PubMed ID: 30028779
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Assessment of costs associated with adverse events in patients with cancer.
    Wong W; Yim YM; Kim A; Cloutier M; Gauthier-Loiselle M; Gagnon-Sanschagrin P; Guerin A
    PLoS One; 2018; 13(4):e0196007. PubMed ID: 29652926
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Malignancy in Renal Transplant Recipients Exposed to Cyclophosphamide Prior to Transplantation for the treatment of Native Glomerular Disease.
    Jorgenson MR; Descourouez JL; Singh T; Astor BC; Panzer SE
    Pharmacotherapy; 2018 Jan; 38(1):51-57. PubMed ID: 29136299
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Approaches to regional lymph node metastasis in patients with head and neck mucosal melanoma.
    Amit M; Tam S; Abdelmeguid AS; Roberts DB; Raza SM; Su SY; Kupferman ME; DeMonte F; Hanna EY
    Cancer; 2018 Feb; 124(3):514-520. PubMed ID: 29044491
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. [Mohs micrographic surgery: 27 year experience in the Northeast of Mexico].
    Cortés-Peralta EC; Garza-Rodríguez V; Vázquez-Martínez OT; Gutiérrez-Villarreal IM; Ocampo-Candiani J
    Cir Cir; 2017; 85(4):279-283. PubMed ID: 27955856
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Genetic profile of GNAQ-mutated blue melanocytic neoplasms reveals mutations in genes linked to genomic instability and the PI3K pathway.
    Pérez-Alea M; Vivancos A; Caratú G; Matito J; Ferrer B; Hernandez-Losa J; Cortés J; Muñoz E; Garcia-Patos V; Recio JA
    Oncotarget; 2016 May; 7(19):28086-95. PubMed ID: 27057633
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Specialized surveillance for individuals at high risk for melanoma: a cost analysis of a high-risk clinic.
    Watts CG; Cust AE; Menzies SW; Coates E; Mann GJ; Morton RL
    JAMA Dermatol; 2015 Feb; 151(2):178-86. PubMed ID: 25389712
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Melanoma patients receive more follow-up care than current guideline recommendations: a study of 546 patients from the general Dutch population.
    Holterhues C; van de Poll-Franse LV; de Vries E; Neumann HA; Nijsten TE
    J Eur Acad Dermatol Venereol; 2012 Nov; 26(11):1389-95. PubMed ID: 22035105
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. [Efficacy and toxicity of erlotinib in non-small cell lung cancer treatment].
    Romero-Ventosa EY; Mucientes-Molina A; Pedrido-Reino E; Lago-Rivero N; Constenla-Caramés L; Arias-Santos I
    Farm Hosp; 2012; 36(2):68-76. PubMed ID: 21798783
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.